DSpace Repository

Anti-cancer Investigation of Newly Derived Alicyclic ring and Morpholine Supported Hybrid Molecules by Industrially viable Route

Show simple item record

dc.contributor.author Kapadiya, K .
dc.contributor.author Pandya, M.
dc.contributor.author Rathod, C.
dc.contributor.author Dhalani, J.
dc.contributor.author Dhaduk, B.
dc.date.accessioned 2024-11-19T11:18:42Z
dc.date.available 2024-11-19T11:18:42Z
dc.date.issued 2018
dc.identifier.citation Kapadiya, K., Pandya, M., Rathod, C., Dhalani, J., & Dhaduk, B. (2018). Anti-cancer investigation of newly derived alicyclic ring and morpholine supported hybrid molecules by industrially viable route. en_US
dc.identifier.uri http://10.9.150.37:8080/dspace//handle/atmiyauni/1707
dc.description.abstract In an attempt to design and synthesize a new class of anticancer molecules, we have reported coupling of aryl aldehyde, p-toluidine and morpholine based isocyanide with cyclopropane carboxylic acid to generate a small library of 08 compounds (5a-5h) by ugi multicomponent reaction in a single step manner. Structures of the newly synthesized compounds were recognized on the basis of spectral data i.e. 1H NMR, 13C NMR, IR and Mass. These compounds were screened for their anticancer activity against nine basic panels as well as NCI-60 cell-lines. In vitro anticancer studies revealed that the compound 5ashowed maximum potency against HCT-116 in colon cancer cell lines with GI50 values 46.27 µg/ml. en_US
dc.language.iso en en_US
dc.publisher Journal of Scientific & Industrial Research en_US
dc.subject Cyclopropane en_US
dc.subject Anticancer Screening en_US
dc.subject Ugi Multicomponent Reaction en_US
dc.subject Morpholinoethyl Isocyanide en_US
dc.title Anti-cancer Investigation of Newly Derived Alicyclic ring and Morpholine Supported Hybrid Molecules by Industrially viable Route en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account